Smooth Drug Development

Executive Summary

Smooth Drug Development is a full-service Contract Research Organization (CRO) headquartered in San Diego, USA, with a strong operational focus in Europe and Asia. Founded in 2015, the company specializes in planning and conducting Phase I-IV clinical trials and observational programs for both novel and generic drugs. It holds ISO certifications in quality, information security, and business continuity management, underscoring its commitment to operational excellence. As a private entity, Smooth Drug Development serves pharmaceutical clients globally, leveraging its international footprint to offer cost-effective and efficient trial management. The CRO market is growing due to increasing R&D outsourcing, and Smooth is well-positioned to benefit as a mid-sized player with specialized capabilities in complex regions.

Upcoming Catalysts (preview)

• TBDExpansion into a New Therapeutic Area or Geographic Region60% success
• TBDMajor Contract Win with a Top-Tier Pharmaceutical Company40% success
• TBDAchievement of Additional Regulatory Certifications (e.g., GCP, FDA compliance)70% success